At Market Issuance Sales AgreementPeregrine Pharmaceuticals Inc • March 27th, 2009 • In vitro & in vivo diagnostic substances • Colorado
Company FiledMarch 27th, 2009 Industry JurisdictionPeregrine Pharmaceuticals, Inc. a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Wm Smith & Co., a Colorado Corporation (“Wm Smith”), as follows: